IP Library Assignment 022676/0444
Patent Assignment
Reel/Frame 022676/0444

Change of Name

Recorded: 2009-05-12 Pages: 5
Assignor
LYNX THERAPEUTICS, INC.
Executed: 2009-03-08
Assignee
SOLEXA, INC.
CHESTERFORD RESEARCH PARK, LITTLE CHESTERFORD, NR. SAFFRON WALDEN, ESSEX, CB10 1XL, UNITED KINGDOM
Covered Property (1)
Method of Nucleic Acid Amplification
Patent: 8,476,044 →
Application: 12/148,133 →
Publication: US 2008/0286795
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Dec 12, 2008
From: SOLEXA LIMITED
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 021983/0444 →
Assignment of Assignor's Interest May 12, 2009
From: MANTEIA S.A.
To: SOLEXA, LTD.; LYNX THERAPEUTICS, INC.
Reel/Frame 022680/0940 →
Merger Feb 9, 2011
From: SOLEXA, INC.
To: ILLUMINA, INC.
Reel/Frame 025777/0639 →
Change of Name May 9, 2014
From: LYNX THERAPEUTICS INC.
To: SOLEXA, INC.
Reel/Frame 032864/0753 →
Assignment of Assignor's Interest May 9, 2014
From: SMITHKLINE BEECHAM CORPORATION
To: MANTEIA SA
Reel/Frame 032864/0123 →
Assignment of Assignor's Interest May 12, 2014
From: KAWASHIMA, ERIC H.; FARINELLI, LAURENT; MAYER, PASCAL
To: GLAXO GROUP LIMITED
Reel/Frame 032874/0519 →
Assignment of Assignor's Interest May 12, 2014
From: GLAXO GROUP LIMITED
To: SMITHKLINE BEECHAM CORPORATION
Reel/Frame 032868/0831 →